Boehringer Ingelheim – Healthcare Data News

Foundation Medicine Announces Global Collaboration with Boehringer Ingelheim to Advance Biliary Tract Cancer Care

Partnership will focus on developing FoundationOne®CDx as a companion diagnostic for Boehringer Ingelheim’s investigational MDM2-p53 antagonist, BI 907828 January 19, 2023 07:03 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine,...

July 28, 2022July 31, 2022 Collaborations Competitor News Data Partnership Pharma RWE Study

SEQSTER Signs Multi-Year Agreement with Boehringer Ingelheim to Put the Patient at the Center of their Clinical Data

Digital Front Door automates the true patient journey and accelerates RWE SAN DIEGO, July 28, 2022 /PRNewswire/ — Seqster PDM, Inc. (“Seqster“), the leader in patient-centric healthcare data technology announced a 3-year...